Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: A report from the Childrens Oncology Group
Pediatric Blood & Cancer, 08/20/2012Appel BE et al.
This subset analysis demonstrates the chemosensitivity of pediatric lymphocyte–predominant Hodgkin lymphoma (LPHL). Patients who had a complete response to chemotherapy had an excellent EFS and OS without the addition of radiotherapy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.